Anti-inflammatory and vascularprotective properties of 8-prenylapigenin

European Journal of Pharmacology

Volumn 620, Issue 1-3, 2009, Pages 120-130

  Paoletti, Tiziana ^a   Fallarini, Silvia ^a   Gugliesi, Francesca ^b   Minassi, Alberto ^a   Appendino, Giovanni ^a   Lombardi, Grazia ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Antioxidant; Flavonoid; Inflammation; Pro inflammatory mediator; Prostacyclin

Indexed keywords

8 PRENYLAPIGENIN; 8 PRENYLNARINGENIN; APIGENIN DERIVATIVE; BETA ACTIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICHLORODIHYDROFLUORESCEIN DIACETATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DRUG DESIGN; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BLOOD VESSELS; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOTHELIAL CELLS; EPOPROSTENOL; FLAVANONES; FLAVONES; GENE EXPRESSION REGULATION; HUMANS; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PRENYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349114194     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.08.015     Document Type: Article

References (54)

1. Abate A., Yang G., Wong R.J., Schroder H., Stevenson D.K., and Dennery P.A. Apigenin decreases hemin mediated heme oxygenase-1 induction. Free Radic. Biol. Med. 39 (2005) 711-718
2. Ahn M.R., Kunimasa K., Kumazawa S., Nakayama T., Kaji K., Uto Y., Hori H., Nagasawa H., and Ohta T. Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. Mol. Nutr. Food Res. 53 (2009) 643-651
3. Antman E.M., Bennett J.S., Daugherty A., Furberg C., Roberts H., and Taubert K.A. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115 (2007) 1634-1642
4. Bai H.W., and Zhu B.T. Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids. J. Lipid Res. 49 (2008) 2557-2570
5. Beutler B., and Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57 (1988) 505-518
6. Biesalski H.K. Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 724-728
7. Botta B., Vitali A., Menendez P., Misiti D., and Delle Monache G. Prenylated flavonoids: pharmacology and biotechnology. Curr. Med. Chem. 12 (2005) 717-739
8. Brunelleschi S., Penengo L., Lavagno L., Santoro C., Colangelo D., Viano I., and Gaudino G. Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br. J. Pharmacol. 134 (2001) 1285-1295
9. Brunelli E., Minassi A., Appendino G., and Moro L. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 107 (2007) 140-148
10. Cao G., Sofic E., and Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22 (1997) 749-760
11. Caposio P., Gugliesi F., Zannetti C., Sponza S., Mondini M., Medico E., Hiscott J., Young H.A., Gribaudo G., Gariglio M., and Landolfo S. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J. Biol. Chem. 282 (2007) 33515-33529
12. Caughey G.E., Cleland L.G., Penglis P.S., Gamble J.R., and James M.J. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J. Immunol. 167 (2001) 2831-2838
13. Chiang Y.M., Lo C.P., Chen Y.P., Wang S.Y., Yang N.S., Kuo Y.H., and Shyur L.F. Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. Br. J. Pharmacol. 146 (2005) 352-363
14. Choi S.Y., Ha T.Y., Ahn J.Y., Kin S.R., Kang K.S., Hwang I.K., and Kim S. Estrogenic activity of isoflavones and flavones and their structure-activity relationships. Planta Med. 74 (2008) 25-32
15. Dax C.I., Lottspeich F., and Müllner S. In vitro model system for the identification and characterization of proteins involved in inflammatory processes. Electrophoresis 19 (1998) 1841-1847
16. Dong X., Fan Y., Yu L., and Hu Y. Synthesis of four natural prenylflavonoids and their estrogen-like activities. Arch. Pharm. Res. 340 (2007) 372-376
17. Egan K.M., Lawson J.A., Fries S., Koller B., Rader D.J., Smyth E.M., and Fitzgerald G.A. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 (2004) 1954-1957
18. Fallarini S., Miglio G., Paoletti T., Minassi A., Amoruso A., Bardelli C., Brunelleschi S., and Lombardi G. Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br. J. Pharmacol. (2009) 157, 1072-1084
19. Fetalvero K.M., Martin K.A., and Hwa J. Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediat. 82 (2007) 109-118
20. FitzGerald G.A. COX-2 in play at the AHA and the FDA. Trends Pharmacol. Sci. 28 (2007) 303-307
21. FitzGerald G.A., and Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345 (2001) 433-442
22. Gester S., Metz P., Zierau O., and Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1, 1 dimethylallyl)naringenin by europium(III)- catalyzed Claisen rearrangement. Tetrahedron 57 (2001) 1015-1018
23. Hämäläinen M., Nieminen R., Vuorela P., Heinonen M., and Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007 (2007) 1-10
24. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., and Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28 (2000) 1456-1462
25. Hermenegildo C., Oviedo P.J., García-Pérez M.A., Tarín J.J., and Cano A. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J. Pharmacol. Exp. Ther. 315 (2005) 722-728
26. Kanno S., Shouji A., Tomizawa A., Hiura T., Osanai Y., Ujibe M., Obara Y., Nakahata N., and Ishikawa M. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci. 78 (2006) 673-681
27. Kim J.Y., Park S.J., Yun K.J., Cho Y.W., Park H.J., and Lee K.T. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. Eur. J. Pharmacol. 584 (2008) 175-184
28. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
29. Le Bail J.C., Varnat F., Nicolas J.C., and Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130 (1998) 209-216
30. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20 (1999) 1945-1952
31. Lombardi G., Varsaldi F., Miglio G., Papini M.G., Battaglia A., and Canonico P.L. Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress. Eur. J. Pharmacol. 457 (2002) 95-98
32. Lu Y., and Wahl L.M. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J. Immunol. 175 (2005) 5423-5429
33. Marnett L.J., and Kalgutkar A.S. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol. Sci. 20 (1999) 465-469
34. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
35. Miglio G., Varsaldi F., and Lombardi G. Human T lymphocytes express N-methyl-d-aspartate receptors functionally active in controlling T cell activation. Biochem. Biophys. Res. Commun. 338 (2005) 1875-1883
36. Miranda C.L., Stevens J.F., Ivanov V., McCall M., Frei B., Deinzer M.L., and Buhler D.R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 48 (2000) 3876-3884
37. Nidolic D., Li Y., Chadwick L.R., Crubjesic S., Schwab P., Metz P., and van Breemen R.B. Metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus) by human liver microsomes. Drug Metab. Dispos. 32 (2004) 272-279
38. Oseni T., Patel R., Pyle J., and Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 74 (2008) 1656-1665
39. Park E., Levis W.R., Quinn M.R., Park S.Y., and Schuller-Levis G.B. Regulation of nitric oxide induced by mycobacterial lipoarabinomannan in murine macrophages: effects of interferon-beta and taurine-chloramine. Int. J. Lepr. Other Mycobact. Dis. 68 (2000) 444-451
40. Rad M., Huempel M., Schaefer O., Scoemaker R.C., Schleuning W.D., Cohenm A.F., and Burggraaf J. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 62 (2006) 288-296
41. Rahman I., Biswas S.K., and Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72 (2006) 1439-1452
42. Raschke W.C., Baird S., Ralph P., and Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15 (1978) 261-267
43. Rodriguez R.J., Miranda C.L., Stevens J.F., Deinzer M.L., and Buhler D.R. Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem. Toxicol. 39 (2001) 437-445
44. Roelens F., Heldring N., Dhooge W., Bengtsson M., Comhaire F., Gustafsson J.A., Treuter E., and De Keukeleire D. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta. J. Med. Chem. 49 (2006) 7357-7365
45. Schaefer O., Hümpel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 (2003) 359-360
46. Smith C.L., and O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25 (2004) 45-71
47. Soobrattee M.A., Neergheen V.S., Luximon-Ramma A., Aruoma O.I., and Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat. Res. 579 (2005) 200-213
48. Stevens J.F., and Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry 65 (2004) 1317-1330
49. Tolbert T., Thompson J.A., Bouchard P., and Oparil S. Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 104 (2001) 2740-2745
50. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New. Bio. 231 (1971) 232-235
51. Wang L., Tu Y.C., Lian T.W., Hung J.T., Yen J.H., and Wu M.J. Distinctive antioxidant and antiinflammatory effects of flavonols. J. Agric. Food Chem. 54 (2006) 9798-9804
52. Wätjen W., Weber N., Lou Y.J., Wang Z.Q., Chovolou Y., Kampkötter A., Kahl R., and Proksch P. Prenylation enhances cytotoxicity of apigenin and liquiritigenin in rat H4IIE hepatoma and C6 glioma cells. Food Chem. Toxicol. 45 (2007) 119-124
53. Xing D., Nozell S., Chen Y.F., Hage F., and Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler. Thromb. Vasc. Biol. 29 (2009) 289-295
54. Yoon J.H., and Baek S.J. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med. J. 46 (2005) 585-596